Boys with cancer can face infertility as adults. Can storing their stem cells help?

Yahoo! News - Mar 28th, 2025

A groundbreaking medical procedure has been undertaken at the University of Pittsburgh Medical Center, where Jaiwen Hsu, a childhood cancer survivor, became the first person to receive a transplant of sperm-producing stem cells. This study aims to restore fertility in individuals who became infertile due to cancer treatments during childhood. Hsu, who underwent chemotherapy at age 11 for bone cancer, had his testicular cells frozen as part of a long-term research effort. Now 26, he returned to test the feasibility of reimplanting these cells to regain fertility, marking a significant step forward in fertility preservation research.

The implications of this study are profound, as it addresses a critical issue faced by many childhood cancer survivors, 85% of whom survive into adulthood, with about one-third facing infertility due to treatment. The procedure involved a biopsy-like removal of testicular tissue, which contains sperm-producing stem cells, and its safe reimplantation was guided by ultrasound. While the success of the procedure is still undetermined, it represents a hopeful advancement for preserving fertility in prepubescent cancer patients. Similar research is underway for female survivors, highlighting the importance of fertility preservation discussions at the time of diagnosis. This development could pave the way for new reproductive options for cancer survivors globally.

National Institutes Of Health Jaiwen Hsu University Of Pittsburgh Medical Center Sperm Producing Stem Cells Childhood Cancer Fertility Preservation Kyle Orwig Testicular Tissue Ellen Goossens Oncofertility Consortium Mahmoud Salama

Story submitted by Fairstory

RATING

7.8

Fair Story

Consider it well-founded

The article provides a well-rounded and informative account of a groundbreaking medical procedure aimed at restoring fertility in childhood cancer survivors. It excels in clarity, readability, and public interest by presenting a compelling human interest story supported by credible sources. However, the article could benefit from additional perspectives, particularly from independent experts or ethicists, to enhance its balance and address potential ethical concerns. While it effectively communicates the experimental nature of the procedure, further detail on methodology and peer-reviewed research would strengthen its accuracy and transparency. Overall, the article is a valuable contribution to ongoing discussions about fertility preservation and cancer survivor care.

Accuracy

The article presents a factual account of Jaiwen Hsu's stem cell transplant aimed at restoring fertility. It accurately describes the experimental nature of the procedure and the involvement of the University of Pittsburgh Medical Center. The claim that Hsu is the first known recipient of such a transplant aligns with current scientific endeavors in fertility preservation. However, the article would benefit from more detailed verification of specific statistics, such as the survival and infertility rates among childhood cancer survivors, which are critical to understanding the broader context of the study.

Balance

The article provides a balanced perspective by including quotes from both the patient, Jaiwen Hsu, and the lead researcher, Kyle Orwig. It also mentions similar research efforts in Belgium and for female cancer survivors, indicating an effort to present a comprehensive view of fertility preservation research. However, the article could be improved by including perspectives from independent experts or ethicists to discuss the broader implications of such experimental procedures.

Clarity

The article is well-written and easy to understand, with a logical flow of information. It explains complex scientific concepts in a way that is accessible to a general audience. The use of quotes and anecdotes helps to humanize the story and maintain reader interest. The tone is neutral and informative, contributing to the overall clarity of the piece.

Source quality

The article cites credible sources, including researchers from the University of Pittsburgh Medical Center and mentions funding from the National Institutes of Health. These are reputable institutions in the field of medical research. However, the article lacks direct quotes or data from peer-reviewed studies, which would strengthen the reliability of the information presented.

Transparency

The article is transparent about the experimental nature of the procedure and the fact that the results are not yet conclusive. It clearly states that the research has not been peer-reviewed, which is critical for transparency. However, it does not delve deeply into the methodology or potential conflicts of interest, such as the financial or professional stakes of the researchers involved.